Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017401

Chief Medical Officer sold 2,373 shares at $12.01 ($28,500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2022-03-07 Sale −2,373 $12.01 $28,500 20,521 D
Open-market sales · 2,373 sh · avg $12.01 · $28,500
Loading xslF345X03/doc4.xml…